Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population
- PMID: 28520615
- PMCID: PMC5522001
- DOI: 10.1097/QAI.0000000000001450
Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population
Abstract
Background: Previous studies of cardiovascular disease (CVD) among HIV-infected individuals have been limited by the inability to validate and differentiate atherosclerotic type 1 myocardial infarctions (T1MIs) from other events. We sought to define the incidence of T1MIs and risk attributable to traditional and HIV-specific factors among participants in the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) and compare adjusted incidence rates (IRs) to the general population Atherosclerosis Risk in Communities (ARIC) cohort.
Methods: We ascertained and adjudicated incident MIs among individuals enrolled in 7 NA-ACCORD cohorts between 1995 and 2014. We calculated IRs, adjusted incidence rate ratios (aIRRs), and 95% confidence intervals of risk factors for T1MI using Poisson regression. We compared aIRRs of T1MIs in NA-ACCORD with those from ARIC.
Results: Among 29,169 HIV-infected individuals, the IR for T1MIs was 2.57 (2.30 to 2.86) per 1000 person-years, and the aIRR was significantly higher compared with participants in ARIC [1.30 (1.09 to 1.56)]. In multivariable analysis restricted to HIV-infected individuals and including traditional CVD risk factors, the rate of T1MI increased with decreasing CD4 count [≥500 cells/μL: ref; 350-499 cells/μL: aIRR = 1.32 (0.98 to 1.77); 200-349 cells/μL: aIRR = 1.37 (1.01 to 1.86); 100-199 cells/μL: aIRR = 1.60 (1.09 to 2.34); <100 cells/μL: aIRR = 2.19 (1.44 to 3.33)]. Risk associated with detectable HIV RNA [<400 copies/mL: ref; ≥400 copies/mL: aIRR = 1.36 (1.06 to 1.75)] was significantly increased only when CD4 was excluded.
Conclusions: The higher incidence of T1MI in HIV-infected individuals and increased risk associated with lower CD4 count and detectable HIV RNA suggest that early suppressive antiretroviral treatment and aggressive management of traditional CVD risk factors are necessary to maximally reduce MI risk.
Figures
References
-
- Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. Bmj. 2009;338:a3172. - PubMed
-
- Saves M, Chene G, Ducimetiere P, et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2003 Jul 15;37(2):292–298. - PubMed
-
- French MA, King MS, Tschampa JM, da Silva BA, Landay AL. Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells. J Infect Dis. 2009 Oct 15;200(8):1212–1215. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- Z01 CP010176/ImNIH/Intramural NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- U01 AI038855/AI/NIAID NIH HHS/United States
- U01 AI037613/AI/NIAID NIH HHS/United States
- UM1 AI068634/AI/NIAID NIH HHS/United States
- K01 AI071754/AI/NIAID NIH HHS/United States
- U10 EY008052/EY/NEI NIH HHS/United States
- U01 AA020790/AA/NIAAA NIH HHS/United States
- R01 DA012568/DA/NIDA NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- R01 AA016893/AA/NIAAA NIH HHS/United States
- P30 AI027767/AI/NIAID NIH HHS/United States
- U01 AI035042/AI/NIAID NIH HHS/United States
- P30 MH062246/MH/NIMH NIH HHS/United States
- K01 AI070001/AI/NIAID NIH HHS/United States
- U01 AI069434/AI/NIAID NIH HHS/United States
- U01 AI037984/AI/NIAID NIH HHS/United States
- R01 DA011602/DA/NIDA NIH HHS/United States
- K23 EY013707/EY/NEI NIH HHS/United States
- R01 CA165937/CA/NCI NIH HHS/United States
- P30 AI094189/AI/NIAID NIH HHS/United States
- R01 DA026770/DA/NIDA NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- UM1 AI069432/AI/NIAID NIH HHS/United States
- G12 MD007583/MD/NIMHD NIH HHS/United States
- P30 AI054999/AI/NIAID NIH HHS/United States
- U54 MD007587/MD/NIMHD NIH HHS/United States
- R01 DA004334/DA/NIDA NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- R24 AI067039/AI/NIAID NIH HHS/United States
- R56 HL126538/HL/NHLBI NIH HHS/United States
- CIHR/Canada
- U01 AI069432/AI/NIAID NIH HHS/United States
- ZIA CP010214/ImNIH/Intramural NIH HHS/United States
- U01 AI038858/AI/NIAID NIH HHS/United States
- F31 DA035713/DA/NIDA NIH HHS/United States
- U10 EY008057/EY/NEI NIH HHS/United States
- U01 AI068636/AI/NIAID NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- M01 RR000052/RR/NCRR NIH HHS/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- K01 AI093197/AI/NIAID NIH HHS/United States
- U01 AI069918/AI/NIAID NIH HHS/United States
- U01 AA013566/AA/NIAAA NIH HHS/United States
- N02 CP055504/CP/NCI NIH HHS/United States
- KL2 TR002317/TR/NCATS NIH HHS/United States
- U01 AI035043/AI/NIAID NIH HHS/United States
- UL1 TR000083/TR/NCATS NIH HHS/United States
- R01 HL126538/HL/NHLBI NIH HHS/United States
- P30 AI027757/AI/NIAID NIH HHS/United States
- KL2 TR000421/TR/NCATS NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- R56 AI102622/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- R01 AG053100/AG/NIA NIH HHS/United States
- U10 EY008067/EY/NEI NIH HHS/United States
- P30 AI036219/AI/NIAID NIH HHS/United States
- U24 AA020794/AA/NIAAA NIH HHS/United States
- U01 AI068634/AI/NIAID NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials